These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A death due to 4-bromo-2,5-dimethoxyamphetamine. Winek CL; Collom WD; Bricker JD Clin Toxicol; 1981 Mar; 18(3):267-71. PubMed ID: 7237958 [No Abstract] [Full Text] [Related]
3. MDA--another stupefacente. Mack RB N C Med J; 1982 Nov; 43(11):777-8. PubMed ID: 6960259 [No Abstract] [Full Text] [Related]
4. LSD or DOB? Davis WM Am J Psychiatry; 1982 Dec; 139(12):1649. PubMed ID: 7149079 [No Abstract] [Full Text] [Related]
5. Vasospasm in the neonate: response to tolazoline infusion. Heath RE Pediatrics; 1986 Mar; 77(3):405-8. PubMed ID: 3951921 [No Abstract] [Full Text] [Related]
6. Identification and quantitation of 4-bromo-2,5-dimethoxyamphetamine in seized blotters. Burrai L; Nieddu M; Palomba M; Pirisi MA Leg Med (Tokyo); 2015 Jan; 17(1):56-9. PubMed ID: 25248801 [TBL] [Abstract][Full Text] [Related]
8. Bromo-DMA: the Australasian hallucinogen? Buhrich N; Morris G; Cook G Aust N Z J Psychiatry; 1983 Sep; 17(3):275-9. PubMed ID: 6580896 [TBL] [Abstract][Full Text] [Related]
9. Bromo-DMA: new hallucinogenic drug. Delliou D Med J Aust; 1980 Jan; 1(2):83. PubMed ID: 7360100 [No Abstract] [Full Text] [Related]
10. [Determination of 4-bromo-2,5-dimethoxyamphetamine (DOB) found in illicit tablets seized in Italy]. Furnari C; Ottaviano V; Rosati F Ann Ist Super Sanita; 2001; 37(2):297-300. PubMed ID: 11758288 [TBL] [Abstract][Full Text] [Related]
11. Arterial changes during treatment with intrahepatic arterial infusion of 5-fluorouracil. Forsberg L; Hafstrom L; Lunderquist A; Sundqvist K Radiology; 1978 Jan; 126(1):49-52. PubMed ID: 619435 [TBL] [Abstract][Full Text] [Related]
12. Use of tolazoline to counteract vasospasm in peripheral arterial catheters in neonates. Lemke RP; al-Saedi SA; Belik J; Casiro O Acta Paediatr; 1996 Dec; 85(12):1497-8. PubMed ID: 9001665 [TBL] [Abstract][Full Text] [Related]
13. [Bromo-dragon fly--life-threatening drug. Can cause tissue necrosis as demonstrated by the first described case]. Thorlacius K; Borna C; Personne M Lakartidningen; 2008 Apr 16-22; 105(16):1199-200. PubMed ID: 18522262 [No Abstract] [Full Text] [Related]
14. Ergotism as a cause of acute vasospastic disease with features mimicking severe atherosclerosis. Abercrombie D; Oehlert WH J Okla State Med Assoc; 1984 Mar; 77(3):86-9. PubMed ID: 6425470 [No Abstract] [Full Text] [Related]
15. (R)-(-)-[77Br]4-bromo-2,5-dimethoxyamphetamine labels a novel 5-hydroxytryptamine binding site in brain membranes. Peroutka SJ; Hamik A; Harrington MA; Hoffman AJ; Mathis CA; Pierce PA; Wang SS Mol Pharmacol; 1988 Oct; 34(4):537-42. PubMed ID: 3173334 [TBL] [Abstract][Full Text] [Related]
17. Intraventricular injections of galanin counteract development of head twitches induced by the 5-HT-2 agonist 1-(2,5-dimethoxyphenyl-4-bromo)-2-aminopropane. Ogren SO; Fuxe K Acta Physiol Scand; 1989 Jun; 136(2):297-8. PubMed ID: 2476910 [No Abstract] [Full Text] [Related]
18. [Studies on the identification of psychotropic substances. VI. Preparation and various analytical data of reference standards of some hallucinogens, 2,5-dimethoxy-4-methylamphetamine (STP), 2,5-dimethoxy-4-bromoamphetamine (DOB) and 2,5-dimethoxy-4-ethylamphetamine (DOET)]. Shimamine M; Takahashi K; Nakahara Y Eisei Shikenjo Hokoku; 1989; (107):113-9. PubMed ID: 2636911 [TBL] [Abstract][Full Text] [Related]
19. Local complications with intravenous diazepam. Donaldson D; Gibson G J Can Dent Assoc; 1979 Jul; 45(7):337-41. PubMed ID: 224979 [No Abstract] [Full Text] [Related]